Science 37 Holdings, Inc.

Informe acción NasdaqCM:SNCE

Capitalización de mercado: US$34.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Salud financiera de hoja de balance de Science 37 Holdings

Salud financiera controles de criterios 5/6

Science 37 Holdings tiene un patrimonio de los accionistas total de $51.7M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $75.7M y $24.0M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$56.41m
PatrimonioUS$51.74m
Total pasivoUS$23.98m
Activos totalesUS$75.73m

Actualizaciones recientes sobre salud financiera

Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Apr 11
Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Nov 04
We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Recent updates

Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks

Dec 18
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks

Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)

Apr 17
Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)

Science 37, Syapse team for faster patient enrollment in cancer trials

Aug 18

Science 37 reports Q2 mixed earnings; narrows FY22 guidance

Aug 11

Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

May 13
Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Apr 11
Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Science 37: Pioneering Decentralized Clinical Trials

Jan 02

We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Nov 04
We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($75.5M) de SNCE superan a sus pasivos a corto plazo ($18.1M).

Pasivo a largo plazo: Los activos a corto plazo de SNCE ($75.5M) superan a sus pasivos a largo plazo ($5.9M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: SNCE está libre de deudas.

Reducción de la deuda: SNCE no ha tenido ninguna deuda en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: SNCE tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: SNCE dispone de suficiente cash runway para 1.4 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 36.9% cada año.


Descubre empresas con salud financiera